Dec. 24 at 1:59 PM
$AKTX Credit where it’s due: initiating GMP manufacturing for AKTX-101 is real execution by the AKTX leadership team. This is not hype — it’s a concrete, costly, and necessary step toward IND and first-in-human trials. Early-stage science is only as good as management’s ability to move it forward, and last action of
$AKTX show discipline, planning, and commitment.
